Dose-related antipermeability effect of terbutaline and its inhibition by a selective beta 2-receptor blocking agent.
Svensjö
E
E
Roempke
K
K
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects*; D006224:Cricetinae; D006632:Histamine / Q000494:pharmacology; D008297:Male; D011217:Practolol / Q000031:analogs & derivatives / Q000494:pharmacology; D011294:Prenalterol; D011412:Propanolamines / Q000494:pharmacology; D013726:Terbutaline / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C026777:ICI 118551; D006632:Histamine; D011294:Prenalterol; D013726:Terbutaline; D011217:Practolol